1-3 of 3
Johan Baeck, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

B-1239, a Novel Anti-BAFF-R Afucosylated Human Antibody, Promotes Potent Natural Killer Cell- Mediated Antibody Dependent Cellular Cytotoxicity In Chronic Lymphocytic Leukemia Cells In- Vitro and Depletion Of Circulating Leukemic CLL B Cells In-Vivo

Emily M. McWilliams, B.S., Carolyn Cheney, B.S, Jeffrey A. Jones, MD, MPH, Joseph M. M. Flynn, DO, MPH, Kami Maddocks, MD, Leslie A. Andritsos, MD, Heather Huet, PhD, Hermann Gram, Ph.D., Johan Baeck, MD, Natarajan Muthusamy, DVM, Ph.D, John C. Byrd, MD
Journal: Blood
Blood (2013) 122 (21): 4185.
https://doi.org/10.1182/blood.V122.21.4185.4185
Published: 2013
Journal Articles

Multi-Trial Safety Evaluation of the Fully Antagonistic Human Anti-CD40 Monoclonal Antibody Lucatumumab (HCD122) in Patients with Relapsed or Refractory B-Cell Malignancies,

Michelle Fanale, MD, William I Bensinger, MD, John C. Byrd, MD, Brett Ewald, PhD, Daniel Carreon, PhD, Johan Baeck, MD, Arnold S. Freedman, MD
Journal: Blood
Blood (2011) 118 (21): 3702.
https://doi.org/10.1182/blood.V118.21.3702.3702
Published: 2011
Journal Articles

Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592)

Arnold S. Freedman, MD, John Kuruvilla, MD, Sarit E. Assouline, MD, Andreas Engert, MD, DaeSeog Heo, MD, Philippe Solal-Celigny, MD, Paolo Corradini, MD, Gregor Verhoef, MD, PhD, Michelle A. Fanale, MD, Jennifer Bendiske, PhD, Brett Ewald, PhD, Jyotirmoy Dey, PhD, Johan Baeck, MD, Anas Younes, MD
Journal: Blood
Blood (2010) 116 (21): 284.
https://doi.org/10.1182/blood.V116.21.284.284
Published: 2010